These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 25471075

  • 1. Prognostic value and clinical implication of serum ferritin levels following allogeneic hematopoietic cell transplantation.
    Nakamae M, Nakamae H, Koh S, Koh H, Nishimoto M, Nakashima Y, Nakane T, Hirose A, Hino M.
    Acta Haematol; 2015; 133(3):310-6. PubMed ID: 25471075
    [Abstract] [Full Text] [Related]

  • 2. Ferritin concentrations correlate to outcome of hematopoietic stem cell transplantation but do not serve as biomarker of graft-versus-host disease.
    Großekatthöfer M, Güclü ED, Lawitschka A, Matthes-Martin S, Mann G, Minkov M, Peters C, Seidel MG.
    Ann Hematol; 2013 Aug; 92(8):1121-8. PubMed ID: 23604429
    [Abstract] [Full Text] [Related]

  • 3. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.
    Busca A, Falda M, Manzini P, D'Antico S, Valfrè A, Locatelli F, Calabrese R, Chiappella A, D'Ardia S, Longo F, Piga A.
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730
    [Abstract] [Full Text] [Related]

  • 4. Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation.
    Mahindra A, Bolwell B, Sobecks R, Rybicki L, Pohlman B, Dean R, Andresen S, Sweetenham J, Kalaycio M, Copelan E.
    Br J Haematol; 2009 Aug; 146(3):310-6. PubMed ID: 19508292
    [Abstract] [Full Text] [Related]

  • 5. Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation.
    Pullarkat V, Blanchard S, Tegtmeier B, Dagis A, Patane K, Ito J, Forman SJ.
    Bone Marrow Transplant; 2008 Dec; 42(12):799-805. PubMed ID: 18762767
    [Abstract] [Full Text] [Related]

  • 6. Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation.
    Kataoka K, Nannya Y, Hangaishi A, Imai Y, Chiba S, Takahashi T, Kurokawa M.
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):195-204. PubMed ID: 19167679
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Impact of hyperferritinemia on the outcome of reduced-intensity conditioning allogeneic hematopoietic cell transplantation for lymphoid malignancies.
    Barba P, Valcárcel D, Pérez-Simón JA, Fernández-Avilés F, Piñana JL, Martino R, López-Anglada L, Rovira M, Garcia-Cadenas I, Novelli S, Carreras E, López Corral L, Sierra J.
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):597-601. PubMed ID: 23305680
    [Abstract] [Full Text] [Related]

  • 10. Hyperferritinemia after adult allogeneic hematopoietic cell transplantation: quantification of iron burden by determining non-transferrin-bound iron.
    Goto T, Ikuta K, Inamoto Y, Kamoshita S, Yokohata E, Koyama D, Onodera K, Seto A, Watanabe K, Imahashi N, Tsukamoto S, Ozawa Y, Sasaki K, Ito M, Kohgo Y, Miyamura K.
    Int J Hematol; 2013 Jan; 97(1):125-34. PubMed ID: 23264147
    [Abstract] [Full Text] [Related]

  • 11. Pretransplant serum ferritin and C-reactive protein as predictive factors for early bacterial infection after allogeneic hematopoietic cell transplantation.
    Kanda J, Mizumoto C, Ichinohe T, Kawabata H, Saito T, Yamashita K, Kondo T, Takakura S, Ichiyama S, Uchiyama T, Ishikawa T.
    Bone Marrow Transplant; 2011 Feb; 46(2):208-16. PubMed ID: 20436524
    [Abstract] [Full Text] [Related]

  • 12. Transfusion-associated iron overload as an adverse risk factor for transplantation outcome in patients undergoing reduced-intensity stem cell transplantation for myeloid malignancies.
    Kim YR, Kim JS, Cheong JW, Song JW, Min YH.
    Acta Haematol; 2008 Feb; 120(3):182-9. PubMed ID: 19129689
    [Abstract] [Full Text] [Related]

  • 13. Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantation.
    Lim ZY, Fiaccadori V, Gandhi S, Hayden J, Kenyon M, Ireland R, Marsh J, Ho AY, Mufti GJ, Pagliuca A.
    Leuk Res; 2010 Jun; 34(6):723-7. PubMed ID: 19944463
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Elevations of tumor necrosis factor receptor 1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Willems E, Humblet-Baron S, Dengis O, Seidel L, Beguin Y, Baron F.
    Bone Marrow Transplant; 2010 Sep; 45(9):1442-8. PubMed ID: 20062090
    [Abstract] [Full Text] [Related]

  • 20. Prognostic impact of posttransplantation iron overload after allogeneic stem cell transplantation.
    Meyer SC, O'Meara A, Buser AS, Tichelli A, Passweg JR, Stern M.
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):440-4. PubMed ID: 23089566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.